News Chart Daxor Corporation

Equities

DXR

US2394671034

End-of-day quote Nasdaq Other stock markets 03:30:00 24/06/2024 am IST			5-day change	1st Jan Change
9.36 ^USD	+2.74%		+6.00%	-2.50%

05/06	Daxor Corporation Appoints John L. Jefferies as Chief Medical Officer	CI
16/04	Daxor Corporation Announces Two New Studies Validating the Clinical Benefits of Daxor?s Blood Volume (BVA-100TM) Diagnostic In Ambulatory Heart Failure Patients For Measurement of Congestion	CI

8a3f42bbd0a03065e.0Ap1SliV_J63_UsotXN9_iUcMxFYRq0kn84bKSIBhyw.pk82GwDjn9OEkxFDzF4-uVFEfUQJC_V-8KteHGNitn61ekImPaDFptOHcw~f3dea263ca1b60e7492f049d9506b098